Osteoporosis treatment [Bonvironju] released once every three months
KyungDong Pharm Co., Ltd. launched ‘Bonviron Injection’, an osteoporosis treatment that is administered by injection once every three months. Bonviron is a bisphosphonate-based osteoporosis treatment containing Ibandronate as the main ingredient. It is a product that is very convenient for patients because it is administered every three months. In the case of existing oral medications of the same class, there were products that maintained the administration cycle for a long time, such as once-weekly therapy or once-monthly therapy, but due to the nature of this agent, it had the disadvantage of being inconvenient to take and concerns about gastrointestinal side effects. On the other hand, Bonvironju is a preparation that is becoming a new trend in osteoporosis treatment because it allows daily life without discomfort after administration and has fewer gastrointestinal side effects compared to oral medications. KyungDong Pharm Co., Ltd.'s osteoporosis treatment products include Bonviron 35mg and 150mg oral tablets, and the addition of Bonviron, an injection therapy administered once every three months, is expected to open a new horizon in the field of orthopedics, which has been weak so far.
☆ Product Information ☆
1. Product name: Bonvironju
2. Ingredient content: 3.375 mg of sodium ibandronate monohydrate in 1 prefilled syringe (3 ml)
3. Efficacy: Treatment of osteoporosis in postmenopausal women
4. Dosage: Inject 3 mg of ibandronic acid intravenously for 15 to 30 seconds once every three months.
5. Packaging unit; 1syr./case
6. Product code: 648103560
※ For other details, please refer to the product manual.